Related Experiment Videos

Inhibition of interferon-gamma-induced intercellular adhesion molecule-1 expression on human keratinocytes by

M Hertl1, L M Neckers, S I Katz

  • 1Dermatology Branch, National Cancer Institute, Bethesda, Maryland 20892, USA.

Insights

Antisense oligonucleotides targeting intercellular adhesion molecule-1 (ICAM-1) mRNA can inhibit its expression in skin cells. A specific S-ODN in the 3' untranslated region effectively reduced ICAM-1, demonstrating potential for treating inflammatory skin diseases.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Immunology

Background:

  • Intercellular adhesion molecule-1 (ICAM-1) expression on keratinocytes is crucial in T-cell-mediated inflammatory skin diseases.
  • Targeting ICAM-1 offers a potential therapeutic strategy for these conditions.

Purpose of the Study:

  • To investigate the selective modulation of ICAM-1 expression in keratinocytes using antisense oligonucleotides (S-ODN).
  • To assess the efficacy of S-ODN targeting different regions of ICAM-1 mRNA.

Main Methods:

  • Two S-ODN targeting ICAM-1 mRNA (translation initiation and 3' untranslated regions) were introduced into keratinocyte cultures via lipid complexes.
  • Interferon-gamma was used to induce ICAM-1 expression, followed by quantification using flow cytometry.
  • Control experiments included phosphodiester ODN (PD-ODN), sense ODN, and scrambled S-ODN.

Main Results:

  • An S-ODN targeting the 3' untranslated region of ICAM-1 mRNA inhibited expression in up to 75% of keratinocytes.
  • This inhibition was sequence-specific and reversible, with minimal impact on other cell surface molecules like beta 2-microglobulin and integrins.
  • Non-specific inhibition was observed with some scrambled S-ODN, indicating complex mechanisms of action.

Conclusions:

  • Antisense S-ODN can selectively inhibit ICAM-1 expression in keratinocytes, particularly when targeting the 3' untranslated region.
  • The findings suggest potential for developing targeted therapies for inflammatory skin conditions by modulating ICAM-1.
  • Both sequence-specific and non-specific mechanisms contribute to the observed effects of S-ODN.

Related Concept Videos